Intranasal vaccines adjuvanted with Nexavant demonstrate robust protective efficacy by inducing both mucosal and systemic immunity in a murine model.

Front Immunol · 2025 · PMC12855080 · PMID 41624860

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Although the H1N1+NVT (i.m.) group showed slightly higher IgG levels compared to H1N1 alone, this difference did not reach statistical significance ( Figure 2B ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.